134 related articles for article (PubMed ID: 22300351)
1. Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation.
Prinz Vavricka BM; Hofbauer GF; Dummer R; French LE; Kempf W
Clin Exp Dermatol; 2012 Aug; 37(6):620-5. PubMed ID: 22300351
[TBL] [Abstract][Full Text] [Related]
2. Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod.
Babel N; Eibl N; Ulrich C; Bold G; Sefrin A; Hammer MH; Rosenberger C; Reinke P
Transpl Infect Dis; 2008 Feb; 10(1):59-62. PubMed ID: 17428275
[TBL] [Abstract][Full Text] [Related]
3. [Clinical remission of classic Kaposi sarcoma with topical 5% imiquimod].
Echeverría-García B; Sanmartín O; Guillén C
Actas Dermosifiliogr; 2010 Mar; 101(2):181-2. PubMed ID: 20223165
[No Abstract] [Full Text] [Related]
4. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Brown VL; Atkins CL; Ghali L; Cerio R; Harwood CA; Proby CM
Arch Dermatol; 2005 Aug; 141(8):985-93. PubMed ID: 16103328
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
Célestin Schartz NE; Chevret S; Paz C; Kerob D; Verola O; Morel P; Lebbé C
J Am Acad Dermatol; 2008 Apr; 58(4):585-91. PubMed ID: 18068265
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
Campistol JM; Schena FP
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma in renal transplant patients: experience at the Cruces Hospital in Bilbao.
Mitxelena J; Gomez-Ullate P; Aguirre A; Rubio G; Lampreabe I; Díaz-Pérez JL
Int J Dermatol; 2003 Jan; 42(1):18-22. PubMed ID: 12581135
[TBL] [Abstract][Full Text] [Related]
9. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
Volkow P; Zinser JW; Correa-Rotter R
BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
[TBL] [Abstract][Full Text] [Related]
10. Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.
Rosen T
Int J Dermatol; 2006 Jul; 45(7):854-6. PubMed ID: 16863526
[No Abstract] [Full Text] [Related]
11. Imiquimod for the treatment of classical Kaposi's sarcoma.
Bernardini B; Faggion D; Calabró L; Oro E; Alaibac M
Acta Derm Venereol; 2010 Jul; 90(4):417-8. PubMed ID: 20574613
[No Abstract] [Full Text] [Related]
12. Kaposi Sarcoma in the Era of Rapamycin Remains a Therapeutic Challenge in Organ Transplant Recipients.
Tunçer Vural A; Karataş Toğral A; Güleç AT; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):25-27. PubMed ID: 29527986
[TBL] [Abstract][Full Text] [Related]
13. Topical imiquimod 5% as a treatment for localized genital Kaposi's sarcoma in an HIV-negative man: a case report.
Fairley JL; Denham I; Yoganathan S; Read TR
Int J STD AIDS; 2012 Dec; 23(12):907-8. PubMed ID: 23258836
[TBL] [Abstract][Full Text] [Related]
14. Regression of post-transplant Kaposi's sarcoma using sirolimus.
Kolhe N; Mamode N; Van der Walt J; Pattison J
Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus for the treatment of Kaposi sarcoma after renal transplantation: a series of 10 cases.
Yaich S; Charfeddine K; Zaghdane S; El Aoud N; Jarraya F; Kharrat M; Hachicha J
Transplant Proc; 2012 Nov; 44(9):2824-6. PubMed ID: 23146533
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression.
Duman S; Töz H; Aşçi G; Alper S; Ozkahya M; Unal I; Celik A; Ok E; Başçi A
Nephrol Dial Transplant; 2002 May; 17(5):892-6. PubMed ID: 11981080
[TBL] [Abstract][Full Text] [Related]
17. Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report.
Detroyer D; Deraedt K; Schöffski P; Hauben E; Lagrou K; Naesens M; Delforge ML; Kuypers D
Transpl Infect Dis; 2015 Apr; 17(2):303-7. PubMed ID: 25645490
[TBL] [Abstract][Full Text] [Related]
18. Kaposi sarcoma after kidney transplantation.
Einollahi B
Iran J Kidney Dis; 2007 Jul; 1(1):2-11. PubMed ID: 19357436
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment with liposomal doxorubicin and foscarnet in a patient with widespread Kaposi's sarcoma and human herpes virus 8-related, serious hemophagocytic syndrome, after renal transplantation].
Bossini N; Sandrini S; Setti G; Luppi M; Maiorca P; Maffei C; Cancarini G
G Ital Nefrol; 2005; 22(3):281-6. PubMed ID: 16001371
[TBL] [Abstract][Full Text] [Related]
20. Risk of Kaposi sarcoma after solid organ transplantation in the United States.
Cahoon EK; Linet MS; Clarke CA; Pawlish KS; Engels EA; Pfeiffer RM
Int J Cancer; 2018 Dec; 143(11):2741-2748. PubMed ID: 29987894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
